The Community Guide

- gsearch

Search Results

Narrow Results:

HAN Health Advisory 1
Journal Article 3

Dispatch 2

1 - 4 of 4 Results

Refine Results

Refine Results:

Introduction and Spread of Dengue Virus 3, Florida, USA, May 2022–April 2023

CITE Title : Introduction and Spread of Dengue Virus 3, Florida, USA, May 2022–April 2023 Personal Author(s) : Jones, Forrest K.;Morrison, Andrea M.;Santiago, Gilberto A.;Rysava, Kristyna;Zimler, Rebecca A.;Heberlein, Lea A.;Kopp, Edgar;Saunders, Katharine E.;Baudin, Samantha;Rico, Edhelene;Mejía-Echeverri, Álvaro;Taylor-Salmon, Emma;Hill, Verity;Breban, Mallery I.;Vogels, Chantal B.F.;Grubaugh, Nathan D.;Paul, Lauren M.;Michael, Scott F.;Johansson, Michael A.;Adams, Laura E.;Munoz-Jordan, Jorge;Paz-Bailey, Gabriela;Stanek, Danielle R.; Corporate Authors(s) : Florida Department of Health Bureau of Public Health Laboratory Team,2 Published Date : 2 2024 Source : Emerg Infect Dis. 2024; 30(2):376-379 URL : https://stacks.cdc.gov/view/cdc/147375 Jones, Forrest K. et al. (2024). Introduction and Spread of Dengue Virus 3, Florida, USA, May 2022–April 2023. 30(2). Jones, Forrest K. et al. "Introduction and Spread of Dengue Virus 3, Florida, USA, May 2022–April 2023" 30, no. 2 (2024) Jones, Forrest K. et al. "Introduction and Spread of Dengue Virus 3, Florida, USA, May 2022–April 2023" vol. 30, no. 2, 2024 Export RIS Citation Information.

:

Jones, Forrest K. ;

Morrison, Andrea M.

2 2024 | Emerg Infect Dis. 2024; 30(2):376-379

:

During May 2022-April 2023, dengue virus serotype 3 was identified among 601 travel-associated and 61 locally acquired dengue cases in Florida, USA. A...
Autochthonous Plasmodium vivax Infections, Florida, USA, 2023

CITE Title : Autochthonous Plasmodium vivax Infections, Florida, USA, 2023 Personal Author(s) : Muneer, Azhar;Adapa, Swamy R.;Silbert, Suzane;Scanlan, Kelly;Vore, Harold;Cannons, Andrew;Morrison, Andrea M.;Stanek, Danielle;Blackmore, Carina;Adams, John H.;Kim, Kami;Jiang, Rays H.Y.;Cui, Liwang; Published Date : 6 2024 Source : Emerg Infect Dis. 2024; 30(6):1214-1217 URL : https://stacks.cdc.gov/view/cdc/157001 Muneer, Azhar et al. (2024). Autochthonous Plasmodium vivax Infections, Florida, USA, 2023. 30(6). Muneer, Azhar et al. "Autochthonous Plasmodium vivax Infections, Florida, USA, 2023" 30, no. 6 (2024) Muneer, Azhar et al. "Autochthonous Plasmodium vivax Infections, Florida, USA, 2023" vol. 30, no. 6, 2024 Export RIS Citation Information.

:

Muneer, Azhar ;

Adapa, Swamy R.

6 2024 | Emerg Infect Dis. 2024; 30(6):1214-1217

:

During May-July 2023, a cluster of 7 patients at local hospitals in Florida, USA, received a diagnosis of Plasmodium vivax malaria. Whole-genome seque...
Concurrent Outbreaks of Hepatitis A, Invasive Meningococcal Disease, and Mpox, Florida, USA, 2021–2022

CITE Title : Concurrent Outbreaks of Hepatitis A, Invasive Meningococcal Disease, and Mpox, Florida, USA, 2021–2022 Personal Author(s) : Doyle, Timothy J.;Gumke, Megan;Stanek, Danielle;Moore, Joshua;Buck, Brian;Locksmith, Timothy;Tomson, Kelly;Schmedes, Sarah;Churchwell, George;Hubsmith, Shan Justin;Krishnamoorthy, Baskar;Poschman, Karalee;Danforth, Brandi;Chacreton, Daniel; Corporate Authors(s) : outbreak investigation team Published Date : 4 2024 Source : Emerg Infect Dis. 2024; 30(4):633-643 URL : https://stacks.cdc.gov/view/cdc/152963 Doyle, Timothy J. et al. (2024). Concurrent Outbreaks of Hepatitis A, Invasive Meningococcal Disease, and Mpox, Florida, USA, 2021–2022. 30(4). Doyle, Timothy J. et al. "Concurrent Outbreaks of Hepatitis A, Invasive Meningococcal Disease, and Mpox, Florida, USA, 2021–2022" 30, no. 4 (2024) Doyle, Timothy J. et al. "Concurrent Outbreaks of Hepatitis A, Invasive Meningococcal Disease, and Mpox, Florida, USA, 2021–2022" vol. 30, no. 4, 2024 Export RIS Citation Information.

:

Doyle, Timothy J. ;

Gumke, Megan

4 2024 | Emerg Infect Dis. 2024; 30(4):633-643

:

In 2022, concurrent outbreaks of hepatitis A, invasive meningococcal disease (IMD), and mpox were identified in Florida, USA, primarily among men who ...
Adverse Effects Linked to Counterfeit or Mishandled Botulinum Toxin Injections

CITE Title : Adverse Effects Linked to Counterfeit or Mishandled Botulinum Toxin Injections Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Center for Preparedness and Response. Published Date : April 23 2024 Series : Health Alert Network Source : HAN ; 507 URL : https://stacks.cdc.gov/view/cdc/154510 Centers for Disease Control and Prevention (U.S.). Center for Preparedness and Response. (2024). Adverse Effects Linked to Counterfeit or Mishandled Botulinum Toxin Injections. (507). Centers for Disease Control and Prevention (U.S.). Center for Preparedness and Response. "Adverse Effects Linked to Counterfeit or Mishandled Botulinum Toxin Injections" , no. 507 (2024) Centers for Disease Control and Prevention (U.S.). Center for Preparedness and Response. "Adverse Effects Linked to Counterfeit or Mishandled Botulinum Toxin Injections" , no. 507, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.). Center for Preparedness and Response.

April 23 2024 | Health Alert Network

:

Distributed via the CDC Health Alert NetworkApril 23 2024, 11:00 AM ETCDCHAN-00507The Centers for Disease Control and Prevention (CDC) is issuing this...